Erratum to: Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis
Sign Up to like & getrecommendations! Published in 2017 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-017-1693-2
Abstract: Corrections to the last section (‘‘Survival’’) on page 1582: Line: 7 Word: 3 TARE should be changed to TACE Word: 9 TACE should be changed to TARE Line: 10 Word: 4 TARE should be changed… read more here.
Keywords: line word; difference; tace; tare ... See more keywords
Comparison of Chemoembolization, Radioembolization, and Transarterial Ethanol Ablation for Huge Hepatocellular Carcinoma (≥ 10 cm) in Tumour Response and Long-Term Survival Outcome
Sign Up to like & getrecommendations! Published in 2021 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-021-02777-6
Abstract: To compare transarterial chemoembolization (TACE), transarterial radioembolization using Yttrium-90 (TARE), and transarterial ethanol ablation (TEA) for huge hepatocellular carcinoma (HCC) in treatment responses and long-term survival outcomes. In this retrospective study approved by institutional committee,… read more here.
Keywords: tace; tare; survival; tea ... See more keywords
Ytrrium-90 transarterial radioembolization in patients with gastrointestinal malignancies
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Translational Oncology"
DOI: 10.1007/s12094-021-02745-z
Abstract: Transarterial radioembolization (TARE) with yttrium-90 (Y90) is a promising alternative strategy to treat liver tumors and liver metastasis from colorectal cancer (CRC), as it selectively delivers radioactive isotopes to the tumor via the hepatic artery,… read more here.
Keywords: tare; transarterial radioembolization; ytrrium transarterial; gastrointestinal malignancies ... See more keywords
Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Surgeons"
DOI: 10.1016/j.jamcollsurg.2019.12.026
Abstract: BACKGROUND Liver-directed hepatic arterial therapies are associated with improved survival and effective symptom control for patients with unresectable neuroendocrine liver metastases (NELM). Whether transarterial chemoembolization (TACE) or transarterial radioembolization (TARE) with yttrium-90 (y-90) are associated… read more here.
Keywords: tace; tare; transarterial chemoembolization; neuroendocrine liver ... See more keywords
Polydopamine-Coated Radiolabeled Microspheres for Combinatorial Radioembolization and Photothermal Cancer Therapy.
Sign Up to like & getrecommendations! Published in 2023 at "ACS applied materials & interfaces"
DOI: 10.1021/acsami.2c19829
Abstract: Transarterial radioembolization (TARE) is a local radionuclide therapy and is successfully used in hepatocellular carcinoma (HCC) treatment. Radioactive microspheres have been widely studied for TARE. Preparation of ideal radioactive microspheres is significant for clinical research… read more here.
Keywords: polydopamine coated; tare; therapy; radioembolization ... See more keywords
Transarterial radioembolization with Yttrium-90: current status and future prospects
Sign Up to like & getrecommendations! Published in 2020 at "Gastroenterology Report"
DOI: 10.1093/gastro/goz074
Abstract: In recent years, transarterial radioembolization (TARE) with Yttrium-90 (Y90) has emerged as a technique for treating malignant neoplasms in the liver. Compared with other locoregional therapies, such as transarterial chemoembolization (TACE), patients who underwent TARE… read more here.
Keywords: tare; treatment; transarterial radioembolization; group ... See more keywords
Patterns of care and outcomes of definitive external beam radiotherapy and radioembolization for localized hepatocellular carcinoma: A propensity score-adjusted analysis.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.4_suppl.329
Abstract: 329 Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide. Most patients with localized HCC are not surgically operable or transplantation candidates, thus there is an increasing role for nonsurgical locoregional therapies.… read more here.
Keywords: hepatocellular carcinoma; tare; propensity score; propensity ... See more keywords
Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenib.
Sign Up to like & getrecommendations! Published in 2018 at "Future oncology"
DOI: 10.2217/fon-2017-0566
Abstract: AIM The aim was to evaluate cost-effectiveness of yttrium-90 transarterial radioembolization (TARE) in comparison to sorafenib treatment. PATIENTS & METHODS A single-center, retrospective, observational study was performed, 166 patients with intermediate-/advanced-stage hepatocellular carcinoma were treated with… read more here.
Keywords: hepatocellular carcinoma; yttrium transarterial; tare; treatment ... See more keywords
Transarterial Radioembolization versus Tyrosine Kinase Inhibitor in Hepatocellular Carcinoma with Portal Vein Thrombosis.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and molecular hepatology"
DOI: 10.3350/cmh.2023.0076
Abstract: Background and aims Transarterial radioembolization (TARE) has shown promising results in treating advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT). However, whether TARE can provide superior or comparable outcomes to tyrosine kinase inhibitor… read more here.
Keywords: hepatocellular carcinoma; tare; pvtt; group ... See more keywords
The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Bioengineering and Biotechnology"
DOI: 10.3389/fbioe.2022.1021499
Abstract: Transarterial embolization (TAE) is a personalized technology that offers precise delivery of chemotherapeutic drugs or selective internal radiation therapy for hepatocellular carcinoma (HCC). Beta-emitting radionuclide embolisms for TAE (β-based TARE) are commonly used in the… read more here.
Keywords: effect alpha; tare; inhibiting effect; based tare ... See more keywords
Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1081479
Abstract: Introduction Although transarterial radioembolization (TARE) using yttrium-90 (90Y) is a treatment option for large hepatocellular carcinoma (HCC), a fraction of patients are ineligible for TARE due to high lung shunt fraction (LSF). Methods We evaluated… read more here.
Keywords: tare; tare eligible; group; tare ineligible ... See more keywords